Oxyrane develops Enzyme Replacement Therapies (ERTs) for the treatment of lysosomal storage diseases (LSDs) using a proprietary engineered yeast expression platform based on Yarrowia lipolytica.

Oxyrane – enzyme replacement therapies

Continue reading →